Another day of divergence for the AIM All Share index which retreated around one and a half points to close at 742.85, failing to find any upside off the back of that China stimulus news.
- Cloudcoco +39%
- Fusion Antibodies +25%
- Ondine Biomedical +20%
- Corcel -21%
- Red Rock Resources -15%
We covered Cloudcoco LON:CLCO yesterday and it’s back on the list again, with some very high volumes being reported although the 39% uptick is barely above the spread quoted at the close. Few investors will have made a turn today on this today.
- AIM Market Roundup: Distil, Orchard Funding, Mirriad Ads
- Small Cap Stocks: MicroSalt, N Brown, Cloudcoco
Fusion Antibodies LON:FAB was in second place, up 25%. There’s no formal news out but some positive broker news from last week could be driving interest. Volumes are reported as significantly elevated.
- Small Cap Stocks: Rockfire Resources, Fusion Antibodies, Oracle Power
- Small Cap Stocks: MicroSalt, N Brown, Cloudcoco
Corcel LON:CRCL was 21% lower on the day. Discounted fundraising news set the pace here with investors failing to see any upside in the acquisition of an enlarged interest in an on-shore Angolan project.
Red Rock Resources LON:RRR was in second to last place, down 15% on the day. Notice of a GM was served mid-way through yesterday’s session but with no reaction on Monday, is this just a case of the market playing catch up? volumes were far from remarkable and the move is barely beyond the spread.
And Ondine Biomedical LON:OBI was 20% higher on the day to take the notable mention. The company announced this morning that it had obtained CAD5m in funding with new shares being sold at a premium. This follows yesterday’s partnership news and the capital is expected to help fund sales growth.
